Katherine E. Varley, Ph.D.

2009 Washington University, Saint Louis, St. Louis, MO 
Molecular Biology, Biochemistry, General
"Katherine Varley"


Sign in to add mentor
Robi D. Mitra grad student 2009 Washington University
 (Methods to identify genetic and epigenetic mutations in cancer.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wallace AD, Sasani TA, Swanier J, et al. (2021) CaBagE: A Cas9-based Background Elimination strategy for targeted, long-read DNA sequencing. Plos One. 16: e0241253
Conway ME, McDaniel JM, Graham JM, et al. (2020) STAT3 and GR cooperate to drive gene expression and growth of basal-like triple-negative breast cancer. Cancer Research
Stewart RL, Matynia AP, Factor RE, et al. (2020) Spatially-resolved quantification of proteins in triple negative breast cancers reveals differences in the immune microenvironment associated with prognosis. Scientific Reports. 10: 6598
Stewart RL, Updike KL, Factor RE, et al. (2019) A multigene assay determines risk of recurrence in patients with triple-negative breast cancer. Cancer Research
Giraddi RR, Chung CY, Heinz RE, et al. (2018) Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development. Cell Reports. 24: 1653-1666.e7
Guillen KP, Scherer SD, Qiao Y, et al. (2018) Abstract LB-038: Predicting breast cancer therapy response using a patient-derived xenograft organoid screening platform Cancer Research. 78
Yang C, Gaffney DK, Werner TL, et al. (2017) Abstract 1756: Genomic reclassification of endometrial carcinoma predicts drug response and facilitates refinement of current management based on PDX-guided efficacy outcomes Cancer Research. 77: 1756-1756
McDaniel JM, Varley KE, Gertz J, et al. (2016) Genomic regulation of invasion by STAT3 in triple negative breast cancer. Oncotarget
Forero A, Li Y, Chen D, et al. (2016) Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells is Associated with a Good Prognosis and Infiltrating Lymphocytes. Cancer Immunology Research
Yang C, Jarboe EA, Gertz J, et al. (2016) Abstract 648: Integrated genomic characterization of endometrial cancer tumor grafts: a step toward genomic-guided treatment Cancer Research. 76: 648-648
See more...